Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.15.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.273NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.13 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.358NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.159NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.510NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.91NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.227NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.555NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.513NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XACNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XZNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EJ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.31.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.367NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.385NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.244NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.17.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.7.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.10.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.351 (Beta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used